CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Laxai Pharma Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Laxai Pharma Ltd.
8905 Regents Park Dr, Suite 210
Phone: (813) 428-3500p:813 428-3500 TAMPA, FL  33647  United States Ticker: LAXAFLAXAF

Business Summary
Laxai Pharma, Ltd. (Laxai), formerly NexGen Biofuels Ltd., is a development-stage company. From March 2010, Laxai, through its fully owned subsidiary OSR Holding Corp., is engaged in the business of providing integrated services across the drug development spectrum out of Laxai subsidiary’s leased facilities in South Plainfield, New Jersey, United States of America. Laxai was engaged through February 2010, in the development and/or acquisition of ethanol and bio-diesel plants, and blending terminal facilities, in the United States. In February 2010, the Company ceased its ethanol and bio-diesel activities. On March 3, 2010, OSR Holding Corp. acquired all the assets of OSR Solutions, Inc. The Company focuses on offering medicinal chemistry, research & development processes, clinical research, collaborative research and blended onshore/off-shore model.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201012/31/2009YesYesYes-Yes

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Managing Director VamsiMaddipatla 2/11/2011 6/1/2010
Chief Executive Officer RamUpadhayaya
Chief Financial Officer NikhilBaheti
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Healthcare Technologies, Ltd
LAXAF
Laxai Avanti Life Sciences Pvt. Ltd
Laxai Pharma Ltd.
NexGen Biofuels, Ltd.
OSR Solutions, Inc

General Information
Number of Employees: 1 (As of 12/31/2009)
Outstanding Shares: 63,378,751 (As of 9/30/2010)
Shareholders: 104
Stock Exchange: OTC
Email Address: info@nexgenbiofuels.net


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023